HHSE Merger Disclosure in Bullet Points * HHSE
Post# of 7290
(Total Views: 555)
Posted On: 04/10/2017 12:34:31 AM
HHSE Merger Disclosure in Bullet Points
* HHSE and another fully registered public equity.
* Mutually executed a letter of intent agreement for a corporate merger
* Significant impact to the financial strength, operations, profile and activities of HHSE
* Contemplated as a stock-for-stock swap
* Hannover House, Inc. shareholders collectively maintaining a majority stock interest and control
* INITIAL (might be more) $65-mm in production and distribution financing arranged for by the merger partner.
* Both partners anticipate that the merger shall become effective following certain regulatory compliances and the remittance of specified payments to Company – both of which events are anticipated to be resolved on or before April 14, 2017.
* Immediate and significant premium value to HHSE shareholders
* Position the Company to fill the currently open market niche’ for a domestic studio focusing on high-quality, mid-level theatrical features (with movies of the budgetary cost and commercial appeal such as “Get Out”, “Little Miss Sunshine”, “Lion” – e.g., quality independent films with budgets of $3-mm to $7-mm and USA box office values approaching $100-mm)
* Merger currently under review and is anticipated to be resolved on or before April 14, 2017
* Upon Merger Closure, Company shall be a fully registered, fully reporting equity, with DTC approved stock trading and the opportunity to quickly uplist to NASDAQ
* HHSE and another fully registered public equity.
* Mutually executed a letter of intent agreement for a corporate merger
* Significant impact to the financial strength, operations, profile and activities of HHSE
* Contemplated as a stock-for-stock swap
* Hannover House, Inc. shareholders collectively maintaining a majority stock interest and control
* INITIAL (might be more) $65-mm in production and distribution financing arranged for by the merger partner.
* Both partners anticipate that the merger shall become effective following certain regulatory compliances and the remittance of specified payments to Company – both of which events are anticipated to be resolved on or before April 14, 2017.
* Immediate and significant premium value to HHSE shareholders
* Position the Company to fill the currently open market niche’ for a domestic studio focusing on high-quality, mid-level theatrical features (with movies of the budgetary cost and commercial appeal such as “Get Out”, “Little Miss Sunshine”, “Lion” – e.g., quality independent films with budgets of $3-mm to $7-mm and USA box office values approaching $100-mm)
* Merger currently under review and is anticipated to be resolved on or before April 14, 2017
* Upon Merger Closure, Company shall be a fully registered, fully reporting equity, with DTC approved stock trading and the opportunity to quickly uplist to NASDAQ
(0)
(0)Hannover House Inc. (HHSE) Stock Research Links
Scroll down for more posts ▼